Skip to content

NP PHARMA

Active
Private limited companyfounded 2025active for 1 yearRésidence du Rieu 8, 7030 Mons, BelgiumKBO/BCE: BE 1019.981.328

From the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette

Summary

NP PHARMA has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €40,694 and a net result of €37,694. Its solvency ranks better than 77% of 22,679 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

History

On 13 February 2025, NP PHARMA was incorporated as a private limited company by one natural person, with a starting capital of €3,000.12 PIZZOFERRATO Nicolas has served as director of the company since 2025.3 The company has filed annual accounts once, for financial year 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 17-02-2025
  3. 3National Bank, annual accounts 2025

Acts, filings and financial milestones

2026
04-07
NBB filing Annual accounts filedNBB
financial year 2025 · micro format
2025
17-02
Gazette deed Incorporation
Appointment: PIZZOFERRATO Nicolas (director) · Founder · Founding capital9 facts ▸
  • Incorporation, “NP PHARMA” (deed in French)
  • Founder, PIZZOFERRATO Nicolas (comparant requérant)
  • Founding capital, €3,000
  • Shareholding, 3000
  • Other provision, “prise d'effet des dispositions finales et transitoires, comparant” (deed in French)
  • Registered office clause, “7030 Saint-Symphorien,résidence du Rieu,8” (deed in French)
  • Board rule, 1
  • Director appointment, PIZZOFERRATO Nicolas (director (not named in the articles))
  • Pre-incorporation commitments, “takeover, tous engagements,obligations et activités entreprises au nom et pour compte de la société en formation” (deed in French)

Open the act in the Belgian Official Gazette

Gazette deedNBB filing

Sources:Publications in the Belgian Official GazetteFilings with the National Bank